[go: up one dir, main page]

DE602006008985D1 - Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund - Google Patents

Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund

Info

Publication number
DE602006008985D1
DE602006008985D1 DE602006008985T DE602006008985T DE602006008985D1 DE 602006008985 D1 DE602006008985 D1 DE 602006008985D1 DE 602006008985 T DE602006008985 T DE 602006008985T DE 602006008985 T DE602006008985 T DE 602006008985T DE 602006008985 D1 DE602006008985 D1 DE 602006008985D1
Authority
DE
Germany
Prior art keywords
ballasts
soluble
composition containing
use against
containing oligosaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006008985T
Other languages
English (en)
Inventor
Marchel Gorselink
Helvoort Adrianus Lambertus Van
Robert Johan Joseph Hageman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36028309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602006008985(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of DE602006008985D1 publication Critical patent/DE602006008985D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/729—Agar; Agarose; Agaropectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pediatric Medicine (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
DE602006008985T 2005-12-16 2006-12-18 Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund Active DE602006008985D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05112336 2005-12-16
PCT/NL2006/050320 WO2007069900A1 (en) 2005-12-16 2006-12-18 Use of soluble dietary fibres against muscle wasting

Publications (1)

Publication Number Publication Date
DE602006008985D1 true DE602006008985D1 (de) 2009-10-15

Family

ID=36028309

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006008985T Active DE602006008985D1 (de) 2005-12-16 2006-12-18 Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund

Country Status (17)

Country Link
US (2) US8143235B2 (de)
EP (1) EP1965669B1 (de)
JP (1) JP2009519328A (de)
CN (2) CN102948659B (de)
AT (1) ATE441333T1 (de)
AU (1) AU2006325591B2 (de)
BR (1) BRPI0619947B1 (de)
CA (1) CA2633292C (de)
DE (1) DE602006008985D1 (de)
DK (1) DK1965669T3 (de)
ES (1) ES2332149T3 (de)
IL (1) IL192219A (de)
NZ (1) NZ569169A (de)
PL (1) PL1965669T3 (de)
RU (1) RU2450815C2 (de)
WO (1) WO2007069900A1 (de)
ZA (1) ZA200805905B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP4610499B2 (ja) * 2006-02-27 2011-01-12 ポーラ化成工業株式会社 食品組成物
CN102131405B (zh) * 2008-06-19 2014-06-11 纽迪希亚公司 用于减肥手术患者的液体营养组合物
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
WO2010002242A1 (en) 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity
EP2320752A1 (de) * 2008-07-18 2011-05-18 Hill's Pet Nutrition, Inc. Verfahren zur verbesserung der lebensqualität eines älteren tiers
AU2010218439B2 (en) 2009-02-24 2016-10-20 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2010143939A1 (en) * 2009-06-09 2010-12-16 N.V. Nutricia Nutrition for improving muscle strength in elderly
EP3202406A1 (de) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und deren verwendungen
CA2831165A1 (en) * 2011-04-18 2012-10-26 Nestec S.A. Nutritional compositions having .alpha.-hica and citrulline and methods of using same
WO2014007606A1 (en) * 2012-07-05 2014-01-09 N.V. Nutricia Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
ES2402643B1 (es) 2012-12-24 2014-01-24 Universitat De Lleida Combinación de fibra anticolesterolémica
MY186844A (en) 2014-07-09 2021-08-25 Cadena Bio Inc Oligosaccharide compositions and methods for producing thereof
WO2016029113A1 (en) * 2014-08-22 2016-02-25 Abbott Laboratories Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate
CN107771083A (zh) 2015-04-23 2018-03-06 卡莱多生物科技有限公司 聚糖治疗剂和治疗方法
RU2757213C2 (ru) * 2016-04-14 2021-10-12 ДюПон НЬЮТРИШН БАЙОСАЙЕНСИЗ АпС Бифидобактерии для увеличения безжировой массы тела
CN106387923B (zh) * 2016-09-07 2019-12-20 中国农业大学 一种富含半乳甘露聚糖的可溶性膳食纤维及其制备方法
EP3357352B1 (de) 2017-02-02 2021-03-24 artgerecht GmbH Zusammensetzung mit aminosäuren
DE102017201713A1 (de) * 2017-02-02 2018-08-02 artgerecht GmbH Zusammensetzung mit Aminosäuren
NL2021737B1 (en) * 2018-10-01 2020-05-07 Nutricia Nv Dietary fiber for treating patients suffering from methylmalonic acidemia and propionic acidemia
JP7401539B2 (ja) * 2018-11-08 2023-12-19 ディーエスエム アイピー アセッツ ビー．ブイ． 胃腸の微生物増殖を選択的に調節する方法
EP4162808A1 (de) * 2018-11-08 2023-04-12 DSM IP Assets B.V. Verfahren zur unterstützung von gastrointestinaler homöostase
AR118985A1 (es) * 2019-05-24 2021-11-17 Cosucra Groupe Warcoing Sa Composición que comprende fibra y proteína
WO2021140225A1 (en) * 2020-01-10 2021-07-15 Cambridge Glycoscience Ltd Oligosaccharide compositions and methods of making them

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5589468A (en) 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
US5641531A (en) * 1995-09-28 1997-06-24 Abbott Laboratories Nutritional liquid supplement beverage and method of making same
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
NZ334021A (en) * 1996-08-09 2001-01-26 Mannatech Inc Dietary supplement containing at least two saccharides being the building blocks of glycoproteins
US5776524A (en) 1996-10-30 1998-07-07 The Iams Company Process for treating small intestine bacterial overgrowth in animals
US5817695A (en) * 1997-12-24 1998-10-06 Pellico; Michael A. Nutritional product with high fat, low carbohydrate and amino acid imbalance
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1282424A1 (de) * 2000-01-07 2003-02-12 Bioenergy Inc. Zusammenstellungen zur Erhöhung der Immunantwort
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
JP2003137790A (ja) * 2001-11-01 2003-05-14 Mie Kariyou Kk β−２，１（β２→β１）結合連鎖フラクトースオリゴマーを含有するフラクトオリゴ糖を有効成分とする医薬
JP2004051942A (ja) * 2002-05-29 2004-02-19 Daicel Chem Ind Ltd 分散体及びそれを用いた成形体の製造方法
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
EP1643861B1 (de) * 2003-07-15 2011-05-11 Nestec S.A. Kalorien- und faserstoffreiche flüssige nahrungszusammensetzung für die darmgesundheit älterer patienten
EP1935425A3 (de) 2003-10-24 2008-09-03 N.V. Nutricia Immunmodulierende Oligosaccharide zur Behandlung und/oder Prävention von chronisch obstruktiver Lungenerkrankung (COPD)
CN1871015B (zh) * 2003-10-24 2010-06-16 努特里奇亚有限公司 免疫调节性寡糖
MX2007013075A (es) * 2005-04-21 2008-01-11 Nutricia Nv Suplemento nutritivo para pacientes con vih.
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system

Also Published As

Publication number Publication date
ES2332149T3 (es) 2010-01-27
US20090203573A1 (en) 2009-08-13
PL1965669T3 (pl) 2010-02-26
RU2450815C2 (ru) 2012-05-20
US20120165243A1 (en) 2012-06-28
US8143235B2 (en) 2012-03-27
BRPI0619947A2 (pt) 2011-10-25
CN101374426A (zh) 2009-02-25
DK1965669T3 (da) 2009-10-05
EP1965669B1 (de) 2009-09-02
US9555059B2 (en) 2017-01-31
BRPI0619947B1 (pt) 2023-10-10
NZ569169A (en) 2012-01-12
CN102948659B (zh) 2014-04-23
CN102948659A (zh) 2013-03-06
EP1965669A1 (de) 2008-09-10
RU2008129102A (ru) 2010-01-27
IL192219A0 (en) 2008-12-29
AU2006325591B2 (en) 2012-07-12
CA2633292C (en) 2015-04-28
CA2633292A1 (en) 2007-06-21
ATE441333T1 (de) 2009-09-15
WO2007069900A1 (en) 2007-06-21
ZA200805905B (en) 2009-10-28
IL192219A (en) 2011-08-31
CN101374426B (zh) 2012-11-28
JP2009519328A (ja) 2009-05-14
AU2006325591A1 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
DE602006008985D1 (de) Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
HRP20050575A2 (en) Triazole derivatives as inhibitors of 11?-hydroxysteroid dehydrogenase-1
NO20071144L (no) Middel for a tilveiebringe substrater basert pa cellulose og/eller stivelse med vannfrastotende og samtidig soppdrepende, antibakterielle, insektfrastotende og algemotvirkende egenskaper
MX2010001560A (es) Composicion farmaceutica que comprende un inhibidor de sglt2 en combinacion con un inhibidor de dpp-iv.
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
PL405074A1 (pl) Zastosowanie alpha-cyklodrkstryny do wytwarzania leku do obnizenia poziomów trójglicerydów
MXPA05009015A (es) Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos.
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
BRPI0414908A (pt) compostos de benzazóis substituìdos, composições e métodos de inibição da atividade raf quinase em um humano ou animal
NO20080010L (no) GPCR-agonister
DE60333937D1 (de) Substituierte quinazolinone verbindungen
ATE551988T1 (de) Orale zusammensetzungen, ihre herstellung und verwendung
MX2010001696A (es) Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo.
CY1109772T1 (el) Χρηση βακτηριδιακων πολυσακχαριτων για αναστολη βιομεμβρανων
MY143599A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
CY1110896T1 (el) Μια νεα αντιμυκητιακη συνθεση
MX2007003157A (es) 4-feniltetrahidroisoquinolinas sustituidas, metodo para su produccion, su uso como medicamento y un medicamento que las contiene.
MXPA05013016A (es) Gaboxadol para el tratamiento de la depresion y otros trastornos afectivos.
SG163540A1 (en) Substituted glycinamides having an antithrombotic and factor xa- inhibiting effect
DE602004031297D1 (de) Kationische flüssige stärkehaltige zusammensetzung und verwendungen davon
PL1965809T3 (pl) Kompozycje do poprawiania zdrowia jelit i użytkowości zwierząt zawierające beta-glukany i alfa-fukany
MX2009003676A (es) Compuestos s-nitrosotiol y derivados relacionados.
AU2003207317A1 (en) Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
TW200508206A (en) Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid, and medicament containing them

Legal Events

Date Code Title Description
8363 Opposition against the patent